Our Team’s Proven Results
Years of Venture Experience
$Million of Cumulative Funding
$Billion in Exits
17 years of venture and entrepreneur experience with early-stage technology companies
Seed-One Ventures (Heat Biologics (HTBX), Firefly Mobile, GenOne), QuickCompliance (Discovery Channel), WebMD, St Jude Medical
B.S. Electrical Engineering, Georgia Institute of Technology; M.B.A., Emory University
30 years of venture and entrepreneur operator experience with Mayfield Fund and early-stage technology companies
Chairman and CEO of ARC International, Fellow at VLSI Technology and CEO of Tamarack Storage Devices, Board Observer for LatticePower and ShineOn, Board Member of Camgian Microsystems and GainSpan
B.S. Nuclear and Electrical Engineering, The University of Texas at Austin
Partner - Proto-n Accelerator
12 years launching and growing national programs to enable entrepreneurs
Co-founded analytics-driven startups aimed at human behavior
MBA, University of Texas; B.S. Chemical Engineering and Finance at Trinity University
Brian Huskinson, PhD
Engagement Manager, McKinsey & Co.
PostDoc, Aziz Lab, Harvard. Inventor of Small organic molecule based flow battery; Technology licensed to Energy firm in Europe
Ph.D., M.S., Applied Physics / Material Science, Harvard University; B.S. Chemical Engineering, Yale University
Anula Jayasuriya, MD, PhD
Founded eXXclaim Capital to capture the compelling yet under invested business opportunity in women’s health in 2017
Board member of Astia Angels focused on investing in women entrepreneurs.
Co-founder and partner, for 10 years, with Evolvence India Life Science to provide growth capital for companies in health care delivery, medical devices and generic pharmaceuticals in India
VC career began with TVM and then Skyline Ventures
AB, MBA, MD & PhD – Harvard
M. Phil in Pharmacology – Cambridge
Co-founded life sciences private equity firm, Symphony Capital in 2002
Co-founder and partner, for 17 years, with The Wilkerson Group and its successor, TWG/IBM Healthcare Consulting, where he was head of the Global Pharmaceutical practice. Consultant with McKinsey from 1980 to 1983
BS Electrical Engineering – Yale and MBA – Columbia
30 years career leading Global Fortune 50 organizations through strategic shifts in core operating model
SVP roles at firms such as GE, IBM, and Coca-Cola, reporting directly to CFO or CEOs such as Lou Gerstner, Jack Welch, and Dennis Dammerman leading operations strategy initiatives.
BS Chemistry, Valparaiso
4 years of early-stage investing in technology companies, Cadenza Innovation, Paradigm4, Plum Perfect; Co-founder Emerging Sun
17 years structured finance experience, led development of Banking on Women business and issuance of first ever Gender Bond (Mizuho Bank, International Finance Corp)
Juris Doctor – Pritzker School of Law, MBA – Kellogg Graduate School of Business, Northwestern University
Founder & Board Chairman of the non-profit Austin Healthcare Council and the Healthcare Velocity Center
30+ year veteran of PE and VC, prolific Angel investor
Founder of one of the nation’s first CVC groups with Ameritech in 1988
Venture Partner, ATP-I. Early advisor & investor in Seismos
Venture Partner, Access Venture Partners
Special Partner, Woodside Venture Partners III
Founder & President, Texas Research and Technology Foundation (TRTF) and Ventex Group, its Venture Capital subsidiary
Everyone engaging with ATP in any manner — including employees, entrepreneurs, clients, customers, and vendors — is required to adhere to our code of conduct to ensure a safe and inclusive environment for all.
We do not tolerate harassment. To report an issue or concern, please contact us by email: admin [at] atpfund [dot] com.
Reports will be reviewed promptly and handled in confidence, as well as investigated and/or otherwise escalated and acted upon as appropriate.